UNSPSC 51392405: Ibopamine

This classification denotes a vasodilating agent with the molecular formula C17H25NO4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3VXW2HU8GS, chemically known as propanoic acid, 2-methyl-, 4-(2-(methylamino)ethyl)-1,2-phenylene ester but generally known as ibopamine, which bears US NIH Compound Identifier 68555. European Medicines Agency schedules Ibopamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08094MIG. The term IBOPAMINE HYDROCHLORIDE is an International Non-Proprietary Name.

UNSPSC 51392405 Ibopamine is a Commodity code whose recent state and local activity does not align with its pharmaceutical ingredient designation. The two recent opportunities tagged under this code — Seminole County, Florida's procurement of naloxone and drug deactivation systems (IFB, due July 26, 2023) and the Texas Health and Human Services Commission's Request for Information on direct-to-manufacturer prescription programs (RFI, due April 3, 2026) — address public health supply chains and pharmacy benefit program design rather than ibopamine specifically. The county procurement solicits finished pharmaceutical products and harm-reduction equipment for community health delivery; the state RFI seeks vendor capabilities for restructuring prescription fulfillment outside traditional pharmacy benefit managers and group purchasing organizations. Issuing bodies include a county health department and a state health commission, both focused on supply chain efficiency and cost management in public health and employee benefit contexts.

The geographic spread is limited to Florida and Texas based on recent posting activity. The Seminole County procurement requires annual delivery of 1,900 units of naloxone and 800 drug deactivation systems with a fixed-fee contract structure, two-year initial term, and one-year renewal option; vendors must comply with E-Verify, drug-free workplace certification, and federal environmental regulations tied to potential FEMA funding. The Texas HHS RFI operates as preliminary market intelligence gathering, with no award values, set-asides, or formal evaluation criteria specified, and is designed to inform future formal solicitation strategy rather than bind the state to specific contract terms. The code shows minimal recent activity and the opportunities posted do not reflect ibopamine procurement — this suggests either misclassification in the state and local tagging system or infrequent direct purchasing of this specific pharmaceutical ingredient at the state and local level.